Literature DB >> 18423418

High glucose downregulates endothelial progenitor cell number via SIRT1.

Maria Luisa Balestrieri1, Monica Rienzo, Francesca Felice, Raffaele Rossiello, Vincenzo Grimaldi, Lara Milone, Amelia Casamassimi, Luigi Servillo, Bartolomeo Farzati, Alfonso Giovane, Claudio Napoli.   

Abstract

Increasing evidence indicates that mammalian SIRT1 mediates calorie restriction and influences lifespan regulating a number of biological molecules such as FoxO1. SIRT1 controls the angiogenic activity of endothelial cells via deacetylation of FoxO1. Endothelial dysfunction and reduced new blood vessel growth in diabetes involve a decreased bioactivity of endothelial progenitor cells (EPCs) via repression of FoxO1 transcriptional activity. The relative contribution of SIRT1 with respect to the direct effects of high glucose on EPC number is poorly understood. We report that treatment of EPCs with high glucose for 3 days determined a consistent downregulation of EPC positive to DiLDL/lectin staining and, interestingly, this was associated with reduced SIRT1 expression levels and enzyme activity, and increased acetyl-FoxO1 expression levels. Moreover, EPCs responded to high glucose with major changes in the expression levels of cell metabolism-, cell cycle-, and oxidative stress-related genes or proteins. Proteomic analysis shows increased expression of nicotinamide phosphoribosyl transferase and mitochondrial superoxide dismutase whereas a glucose-related heat shock protein is reduced. These findings show that SIRT1 is a critical modulator of EPCs dysfunction during alteration of glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423418     DOI: 10.1016/j.bbapap.2008.03.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  32 in total

1.  Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

2.  Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.

Authors:  Jung-Mi Yun; Alexander Chien; Ishwarlal Jialal; Sridevi Devaraj
Journal:  J Nutr Biochem       Date:  2011-08-02       Impact factor: 6.048

Review 3.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

Review 4.  SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.

Authors:  Nunzia D'Onofrio; Luigi Servillo; Maria Luisa Balestrieri
Journal:  Antioxid Redox Signal       Date:  2017-06-29       Impact factor: 8.401

Review 5.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.

Authors:  Ruben Nogueiras; Kirk M Habegger; Nilika Chaudhary; Brian Finan; Alexander S Banks; Marcelo O Dietrich; Tamas L Horvath; David A Sinclair; Paul T Pfluger; Matthias H Tschöp
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

6.  Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients.

Authors:  Francesco Cacciatore; Giuseppe Bruzzese; Dino Franco Vitale; Antonio Liguori; Filomena de Nigris; Carmela Fiorito; Teresa Infante; Francesco Donatelli; Pellegrino Biagio Minucci; Louis Joseph Ignarro; Claudio Napoli
Journal:  Eur J Clin Pharmacol       Date:  2011-03-29       Impact factor: 2.953

7.  Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling.

Authors:  Yuan Yao; Hongzhe Li; Yansong Gu; Nancy E Davidson; Qun Zhou
Journal:  Carcinogenesis       Date:  2009-12-08       Impact factor: 4.944

8.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

9.  Inhibition of transcriptional activity of c-JUN by SIRT1.

Authors:  Zhanguo Gao; Jianping Ye
Journal:  Biochem Biophys Res Commun       Date:  2008-09-26       Impact factor: 3.575

10.  Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation.

Authors:  M L Balestrieri; L Servillo; A Esposito; N D'Onofrio; A Giovane; R Casale; M Barbieri; P Paolisso; M R Rizzo; G Paolisso; R Marfella
Journal:  Diabetologia       Date:  2012-10-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.